World IBD Day 2019

New DealInflammatory bowel diseases, New DealLeave a Comment

Over ten million people worldwide live with IBD, a disease that goes unnoticed by most of the people around them. To increase its visibility today we celebrate world IBD day. Under the motto “Making the invisible visible” over 50 countries are joining this initiative to show support to all the IBD warriors out there and to show to the society … Read More

May New Deal Reads

New DealInflammatory bowel diseases, New Deal ReadsLeave a Comment

A JAK1 Selective Kinase Inhibitor and Tofacitinib Affect Macrophage Activation and Function. De Vries L. C. S et al.Β  Inflammatory Bowel Disease. 25 (4) 2019. Janus kinases (JAKs) are involved in the intestinal inflammation found in IBD. A common treatment for this disease is tofacitinib, a drug that inhibits different JAKs. Although this therapy is effective, it doesn’t target only … Read More